Mangalam Drugs And Organics Ltd. benchmarking: Perfomance to industry peers

Financial

	Mangalam Drugs&Org.	Lasa Supergenerics	Tyche Inds
Operational Metrics
Unclassified
Advertisement Spend as a % of Total Sales	0.5 %	n/a	0.03 %
R&D as a % of Total Sales	3.31 %	n/a	1.28 %
Financials
5 yr Average ROE	-0.44 %	-8.32 %	12.13 %
5yr average Equity Multiplier	2.43	1.44	1.16
5yr Average Asset Turnover Ratio	1.0	0.77	0.53
5yr Avg Net Profit Margin	0.0	-8.22 %	19.18 %
Price to Book	0.31	0.83	0.8
P/E	0.0	0.0	11.66
5yr Avg Cash Conversion Cycle	17.41 Days	11.27 Days	111.78 Days
Inventory Days	132.58 Days	46.83 Days	69.03 Days
Days Receivable	38.43 Days	10.61 Days	101.01 Days
Days Payable	126.53 Days	83.41 Days	90.14 Days
5yr Average Interest Coverage Ratio	0.9	-18.91	2385.83
5yr Avg ROCE	6.92 %	1.03 %	16.3 %
5yr Avg Operating Profit Margin	7.63 %	9.99 %	21.21 %
5 yr average Debt to Equity	0.59	0.2	0.0
5yr CAGR Net Profit	39.54 %	n/a	-9.09 %
5yr Average Return on Assets	-0.18 %	-5.59 %	10.39 %
Shareholdings
Promoter Holding	50.3 %	53.65 %	61.97 %
Share Pledged by Promoters	34.58 %	20.66 %	0.0
Change in Promoter Holding (3 Yrs)	-0.12 %	9.87 %	0.0
Change in Mutual Fund Holding (3 Yrs)	0.0	0.0	0.0

	Mangalam Drugs&Org.	Lasa Supergenerics	Tyche Inds
Product Wise Break-Up	Product Wise Break-Up Pharmaceutical 100.0 Manufacture of bulk drugs intermediates 0	-	Product Wise Break-Up Pharmaceutical 0 Bulk Chemicals 100.0
Location Wise Break-Up	Location Wise Break-Up Domestic 62.61 International 37.39 India 0	Location Wise Break-Up India 95.82 Domestic 0 International 0 Others 4.18	Location Wise Break-Up India 0 Domestic 32.67 International 47.91 Others 19.42
Raw Material Break-Up	Raw Material Break-Up Artimesinin 61.91 Lumefantrine-3 26.55 Ethyl Acetate 2.91 EMME 2.42 PMPA 0 Others 6.21	-	-